News

The 10.5% Yield Of The Preferred Stock Of Chimera Is Attractive (NYSE:CIM.PR.D)

1 Mins read

This article was written by

I am a chemical engineer with a MS in Food Technology and Economics, and a MENSA member. I am the author of the book “Investing in Stocks and Bonds: The Early Retirement Project” (2024):I am also the author of the book “Mental Math: How to perform math calculations in your mind”.I am also the author of 2 other mathematics books (“Arithmetic calculations without a calculator” and “Word Problems”) and perform almost all the calculations in my mind, without a calculator, making it easier to make immediate investing decisions among many alternatives. I invest applying fundamental and technical analysis and mainly use options as a tool for both investing and trading. I achieved my goal of financial independence at the age of 45. In my spare time, I follow Warren Buffett’s principle: “Some men read playboy. I read financial statements”.

Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha’s Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Read the full article here

Related posts
News

Interface Stock: A Flooring Company At An Inflection Point (NASDAQ:TILE)

1 Mins read
This article was written by Follow Robert F. Abbott has been investing his family’s accounts since 1995, and in 2010 added options,…
News

Vivos Therapeutics, Inc. (VVOS) Q4 2024 Earnings Call Transcript

1 Mins read
Vivos Therapeutics, Inc. (NASDAQ:VVOS) Q4 2024 Earnings Conference Call March 31, 2025 5:00 PM ET Company Participants Bradford Amman – CFO, Treasurer…
News

EPAM Systems: Growth Is Finally Returning (NYSE:EPAM)

1 Mins read
This article was written by Follow I am an avid investor with a major focus on small cap companies with experience in…
Get The Latest News

Subscribe to get the top fintech and
finance news and updates.

Leave a Reply

Your email address will not be published. Required fields are marked *